Abstract:Proc Amer Assoc Cancer Res, Volume 47, 2006 4662 Hepatocellular carcinoma (HCC) is one of the most common and lethal solid tumors in the world. HCC is typically refractory to almost all cytotoxic chemotherapeutic agents. OSU-03012 is a derivative of celecoxib, a cyclooxygenase (COX)-2 inhibitor. However, its primary mechanism of action is known as 3-phosphoinositide-dependent kinase-1 (PDK-1) inhibition and by which it induces apoptosis in certain cancer cells[Zhu J et al. , Cancer Res. 64:4309-18, 2004; Hsu AL et al. , J Biol. Chem . 275:11937-403. 2000]. This study sought to investigate if OSU-03012 may be effective in the treatment of HCC. OSU-03012 inhibited cell growth of Huh7, a human HCC cell line, in a dose-dependent manner, with IC50 at 1μM, which is well below the non-toxic serum concentration (5-20μM) in mice. Surprisingly, in this Huh7 cell model, western blotting analysis demonstrated that neither pPDK1 nor pAkt was suppressed by OSU-03012. Cell cycle analysis by flow cytometry indicated that OSU-03012 (5μM, 24h) significantly increased S-phase population, while did not alter sub-G1 population, suggesting that apoptosis is not a major mechanism of cell growth suppression. Western blotting analysis showed that OSU-03012 reduced protein level of cyclin D1. Furthermore, OSU-03012-treated cells exhibited cytoplasmic vacuoles which were positively stained by acridine orange and monodansylcadaverine, a phenomenon mimicking cell autophagy. The content in the OSU-03012-induced autophagosomes and its mechanistic linkage with the occurrence of autophagy-like cell death of Huh7 cells are under investigation. Together, our preliminary results indicate that OSU-03012 might be an effective therapeutic agent for HCC, but the mechanisms of action of this drug in HCC cells need to be further clarified. (This study was supported by grant DOH94-TD-B-111-001 from Department of Health, R.O.C. to National Clinical Research Center at National Taiwan University)

Autophagy of HepG-2 Cells Induced by Novel Oxadiazolo Pyrimidine Nucleoside Derivative

Both DNA Damage and Mitochondrial Dysfunction Are Involved in Novel Oxadiazolo[3,4‐d]pyrimidine Nucleoside Derivatives‐induced Cancer Cell Death

Mitochondria was Involved in Mediating MOPDO-induced Proliferation Inhibition and Apoptosis in HepG2 Cells

Depletion of 4E-Bp1 and Regulation of Autophagy Lead to Yxm110-Induced Anticancer Effects

OAMDP, a novel podophyllotoxin derivative, induces apoptosis, cell cycle arrest and autophagy in hepatoma HepG2 cells.

Osu-03012, A Novel Celecoxib Derivative, Induces A Unique Autophagy-Like Cell Death In Human Hepatocellular Carcinoma Cells

Osu-03012, A Novel Celecoxib Derivative, Induces Reactive Oxygen Species-Related Autophagy In Hepatocellular Carcinoma

Discovery of Dolutegravir Derivative against Liver Cancer via Inducing Autophagy and DNA Damage

Novel oxazolinoanthracyclines as tumor cell growth inhibitors—Contribution of autophagy and apoptosis in solid tumor cells death

Fluorescent hyaluronic acid nanoprodrug: A tumor-activated autophagy inhibitor for synergistic cancer therapy

Synthesis of Novel Oxime-Containing Pyrazole Derivatives and Discovery of Regulators for Apoptosis and Autophagy in A549 Lung Cancer Cells

A Study on Autophagy Inhibited by 3-MA and Oxaliplatin Induce HepG2 Apoptosis

Autophagic Process Induced by Olaquindox in HepG2 Cells

Anti-Tumor Effect of A Novel Dox/Ga-Cdte Qd Was Mediated by Apoptotic and Autophagic Cell Death

Synthesis of Novel 4,7-Disubstituted Quinoline Derivatives As Autophagy Inducing Agents Via Targeting Stabilization of ATG5.

DMH1 (4-[6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline) Inhibits Chemotherapeutic Drug-Induced Autophagy

Discovery of Novel 2-Aminonicotinonitrile Derivatives with New Potential Autophagy Activity

Beclin 1-Mediated Autophagy in Hepatocellular Carcinoma Cells: Implication in Anticancer Efficiency of Oroxylin A Via Inhibition of Mtor Signaling.

Anticancer Potential of Pyridoxine-Based Doxorubicin Derivatives: An In Vitro Study

The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine Sulfonamide Derivatives on Apoptosis and Autophagy in DLD-1 and HT-29 Colon Cancer Cells

Synthesis, Assessment of Antineoplastic Activity, and Molecular Docking of Novel 2-Thioxo-oxazolidin-4-one Derivatives